Corbus is committed to leveraging our expertise in immunology to fulfill our purpose of developing innovative new medicines that improve the lives of people living with inflammatory, fibrotic, and metabolic diseases, and cancer. Our business development strategy is to identify new assets in the immunology space that will diversify our clinical pipeline. We are open to branch into new biologic pathways where there is clear patient need.

We look forward to hearing from you. Please complete this form to contact us.